Newsfeeds - Spark Newswire

1 minute read

F-star Therapeutics Stock Jumps On Licensing Pact For STING Inhibitors With AstraZeneca

Today, 10:21 PM

F-star Therapeutics Inc (NASDAQ:FSTX) has entered into an exclusive licensing agreement with AstraZeneca plc (NASDAQ:AZN) for research, development, and commercialization of next-generation Stimulator…

AZN

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 10:21 PM

ARPO

2 minute read

F-star Therapeutics Enters Exclusive Licensing Agreement With AstraZeneca For Novel STING Inhibitors; F-Star Eligible For Upfront And Near-Term Payments Of $12M And Milestones Of Over $300M

By Bill Haddad

Today, 10:21 PM

F-star Therapeutics, Inc. (NASDAQ:FSTX) ("F-star" or the "Company"), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to

AZN

1 minute read

SVB Leerink Initiates Coverage On F-star Therapeutics with Outperform Rating, Announces Price Target of $39

By Benzinga Newsdesk

Today, 10:21 PM

SVB Leerink analyst Daina Graybosch initiates coverage on F-star Therapeutics (NASDAQ:FSTX) with a Outperform rating and announces Price Target of $39.

FSTX

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 10:21 PM

Gainers

ADMP

5 minute read

Uncategorized

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:21 PM

Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday.

ADAP

6 minute read

Uncategorized

Earnings Scheduled For May 17, 2021

By Benzinga Insights

Today, 10:21 PM

Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter.

ACRX

2 minute read

Uncategorized

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

By Shanthi Rexaline

Today, 10:21 PM

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.

ACRX